# Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583

> **NCT00898833** · — · TERMINATED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 868 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00898833
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2003-07
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 868 (ESTIMATED)
- **Why stopped:** The proposed work could not be completed.
- **Last updated:** 2017-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898833, "Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00898833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
